Amylyx Pharmaceuticals, Inc. (AMLX)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Amylyx Pharmaceuticals, Inc. (AMLX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $2.54B and a free-cash-flow yield of -5.7%. Over the most recent reported fiscal year, revenue declined 100.0%.

Market cap	$2.54B
Trailing P/E	—
FCF yield	-5.7%
Revenue growth (YoY)	-100.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live AMLX data on Nama Insights →

Recent Congressional trades

Amylyx Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Christopher L. Jacobs	House	Buy	$1,001 - $15,000	Nov 11, 2022